LifeStance Health Group, Inc. — Form 8-K
Filed September 11, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
LifeStance Health Group executed a secondary public offering on September 9, 2026 of 22,250,000 common shares at $12.29/share, with selling stockholders TPG VIII Lynnwood Holdings (18.41M shares), Summit Partners Growth Equity Funds IX-A and IX-B (3.82M shares combined), and smaller Summit entities (18k shares combined). Barclays Capital Inc. served as sole underwriter. Simultaneously, the Company repurchased 2,000,000 shares at the same price from the underwriter. Lock-up agreements restrict selling stockholders and company insiders from selling or hedging for 75 days post-closing.
Why this rating
Secondary offering by early investors (TPG/Summit) reduces their stakes; company buyback is modest (2.3% of 87M post-offering shares). Minimal dilution to public shareholders; typical liquidity event for PE/growth equity holders.
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.